Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents.

Blain, Hubert; Tuaillon, Edouard; Gamon, Lucie; Pisoni, Amandine; Miot, Stéphanie; Picot, Marie-Christine

Blain, Hubert; Tuaillon, Edouard; Gamon, Lucie; Pisoni, Amandine; Miot, Stéphanie; Picot, Marie-Christine.

Afiliação

Blain H; Department of Internal Medicine and Geriatrics, MUSE University, Montpellier, France. Electronic address: h-blain@chumontpellier.fr.
Tuaillon E; INSERM U 1058/EFS, University Hospital, Montpellier, France.
Gamon L; Clinical Research and Epidemiology Unit, University Hospital, Montpellier, France.
Pisoni A; INSERM U 1058/EFS, University Hospital, Montpellier, France.
Miot S; Department of Internal Medicine and Geriatrics, MUSE University, Montpellier, France.
Picot MC; Clinical Research and Epidemiology Unit, University Hospital, Montpellier, France.

J Am Med Dir Assoc ; 23(5): 750-753, 2022 05.

Article em En | MEDLINE | ID: mdl-35311651

Assuntos

COVID-19; Vacinas; Anticorpos Antivirais; Formação de Anticorpos; Vacina BNT162; Vacinas contra COVID-19; Estudos de Coortes; Humanos; Imunoglobulina G; Casas de Saúde; SARS-CoV-2

Palavras-chave

BNT162b2 vaccine; SARS-CoV-2 spike antibodies; boost vaccine dose; nursing home residents

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article